Risk factor
Very poor trading liquidity
Profitability factor
Very favourable analyst view
About
Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is overpriced on P/E, 'cheap' on EV/EBITD.
Target Price
The average target price of SHALBY.NS is 310 and suggests 75% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Buy
Sell